We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Global Healthcare Study of Coronary Artery Disease Reaches Significant Milestone

By MedImaging International staff writers
Posted on 11 May 2015
Print article
A major milestone has been reached in the Lipid-Rich Plaque (LRP) study, a prospective, multicenter clinical trial with the potential to reveal breakthrough correlations between Lipid-Rich Plaques and occurrence of heart attacks.

The LPR study has now enrolled 1,000 patients, and aims to identify a correlation between lipid-rich plaques and the occurrence of a cardiac event within two years.

The equipment used in the study to assess vessel structure and plaque composition is the TVC Imaging System, made by Infraredx (Burlington, MA, USA), an intravascular imaging equipment manufacturer. The TVC Imaging System can identify lipid-core plaques, and help researchers develop Percutaneous Coronary Interventions (PCI) as a means to prevent heart attacks.

The study uses a dual-modality intravascular imaging system that integrates Near-Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) technology, allowing clinicians to assess vessel structure and plaque composition. The goal of the study is to prove that vulnerable plaques can be identified by NIRS and provide a target for personalized therapy to prevent coronary events.

Ron Waksman, MD, principal investigator of the LRP Study, said, “With 1,000 patients enrolled at forty-one investigator sites across the United States and Europe, we are excited by the rapid progress of the LRP Study. Once complete, the LRP Study data could redefine the role of intravascular imaging and lay the groundwork for changing standard protocols for managing coronary artery disease.”

Related Links:

Infraredx 


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Doppler System
Doppler BT-200
New
PACS Workstation
CHILI Web Viewer
New
Digital Radiography Generator
meX+20BT lite

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.